Publication | Closed Access

A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation

Cell TherapyDefined DonorTransplantationMarrow TransplantationLeukemic RelapseStem Cell TransplantationImmunologyHematologyAutoimmunityCell BiologyBlood TransplantationImmunotherapyMedicineCell TransplantationNatural Killer Cells